NASDAQ: AXSM · Biotechnology
Over the past week, Axsome Therapeutics (AXSM) drew 16 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 31% bullish but is sharply divided: News runs 93% bullish while X sits at just 0%. Wall Street is more constructive, with 20 of 21 analysts rating AXSM a buy.
There is little buzz around AXSM this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 95% buy share sits next to a crowd that ranges from X at 0% to News at 93%. No other tracker puts the two side by side.
21 analysts have weighed in: a Strong Buy consensus: 20 buy calls against 0 sell, with an average 12-month price target of $285.42.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 64 points above the crowd average of 31%, the professionals are more constructive than retail. The split is inside the crowd: News reads 93% bullish while X sits at 0%, a 93-point spread that single-source trackers miss.
Over the 30-day window, Axsome Therapeutics (AXSM) buzz held subdued around 16.6 while the price drifted down 1.6% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 646K shares. Over the last 7 trading days, AXSM held roughly flat. Buzz activity in the recent week averaged 28.4 and was variable, swinging between 14.0 and 47.7. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 12 of the 19 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for AXSM and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live AXSM sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 04, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (20 / 1 / 0) |
| Crowd bullish (7d) | 31% |
| Avg price target | $285.42 |
| Most bullish source | News, 93% |
| Most bearish source | X, 0% |
| Sentiment spread | 93 pts |
| Mentions (7d) | 16 |
| Market cap | $10.91B |
| P/E · Forward P/E | n/a · 33.7 |
| EPS · Beta | -$3.75 · 0.7 |
| Revenue (TTM) | $776.6M · -25% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Axsome Therapeutics (AXSM) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 31% bullish across 3 active sources. Those sources contribute 16 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Axsome Therapeutics (AXSM) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Axsome Therapeutics (AXSM), averaging 31% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 93% bullish and X at 0%, a 93-point spread. On the professional side, 20 of 21 analysts rate AXSM a buy.
Of the 21 analysts covering Axsome Therapeutics (AXSM), 20 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $285.42. That puts the street ahead of the crowd, which averages 31% bullish.
Axsome Therapeutics (AXSM)'s cross-source average is bearish at 31% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. X reads 0% bullish, News reads 93% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Axsome Therapeutics (AXSM) at 31% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is rising across News. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 14 mentions (88% of total volume). X contributes 2 mentions. The cross-source average is bearish at 31% bullish, while news is the only source with rising 3-day activity. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. AXSM's sell signal at 93/100 conviction reflects a bearish cross-source average at 31% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The AXSM sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key